权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Characterization of beta-cell-specific extracellular vesicle cargo as functional biomarkers for type I DM disease

β细胞特异性细胞外囊泡货物作为 I 型 DM 疾病功能性生物标志物的表征

基本信息

批准号：
10706576
负责人：
Saumya Das
金额：
$ 75.37万
依托单位：
MASSACHUSETTS GENERAL HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-09-19 至 2026-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10706576
关键词：
Address Autoantigens Autocrine Communication Autoimmune Autoimmune Diseases Autoimmunity B-Lymphocytes Beta Cell Bioinformatics Biological Markers Biological Models Biology Blood Bone Marrow Case/Control Studies Cell Line Cell physiology Cells Cellular biology Characteristics Child Childhood Circulation Clinical Communication Communities Data Data Set Detection Development Diabetes Mellitus Discrimination Disease Early Diagnosis Event Funding Genetic Transcription Goals Health Histology Human Human Cell Line Immune Immune response Immune system Immunologics In Vitro Individual Inflammation Inflammatory Injury Insulin Insulin-Dependent Diabetes Mellitus Islet Cell Islets of Langerhans Laboratories Macrophage Measures Mediating Mediator Membrane Membrane Potentials Membrane Proteins Metabolic Diseases Metabolism Methods Mitochondria Modeling Molecular Morbidity - disease rate Mus National Institute of Diabetes and Digestive and Kidney Diseases Natural Immunity Oxidative Stress Pancreas Pancreatic Injury Pathogenesis Pathologic Patients Peripheral Persons Phase Phenotype Plasma Population Predisposition Process Production Proteins Proteomics RNA RNA Databases Reporter Research Risk Role Sentinel Signal Transduction Specificity Stimulus Stress Structure of beta Cell of islet Synapses System Techniques Tissues Transcript Translations United States National Institutes of Health cell injury cohort cytokine diabetes pathogenesis disease diagnostic early detection biomarkers extracellular vesicles glucose uptake human tissue immune activation immunoregulation in vivo insight insulin dependent diabetes mellitus onset intercellular communication islet lipid metabolism monocyte mortality neutrophil novel peripheral blood pre-clinical prevent protein biomarkers response single nucleus RNA-sequencing trafficking transcriptome sequencing translational study

项目摘要

1 Type 1 diabetes (T1D) is an autoimmune disease afflicting nearly 2 million people in the U.S. The loss of insulin- 2 producing β cells in the pancreas results in an absolute requirement for injected insulin, causing significant risks 3 of mortality and morbidity. T1D is characterized by a latent (asymptomatic) phase, during which autoimmune or 4 inflammatory pancreatic beta cell injury is postulated to lead to a decline in beta cell function/mass and ultimately 5 to T1D. A key goal in T1D is halting the autoimmune cellular attack, by limiting immune-mediated damage. The 6 precise intrapancreatic signaling mechanisms that lead to activation of the immune system and early pancreatic 7 injury remain unclear. Identification of markers closely associated with these key immune events in the 8 pathogenesis of T1D that can be detected in peripheral circulation would allow for detection of pre-clinical 9 disease and tracking of disease trajectory. Extracellular vesicles (EVs) and their contents have emerged as novel 10 mediators of intercellular signaling and functional biomarkers in human metabolic diseases. Data from our 11 collaborative group as part of NIH efforts in EV biology (NIH Common Fund) suggest that circulating cell-specific 12 EVs and their cargo as probes for disease trajectory or cellular health provide greater specificity than traditional 13 circulating RNA or protein biomarkers in whole plasma. Recent studies in T1D suggest that pancreatic beta cells 14 under “stress” produce EVs containing auto-antigens and RNA transcripts that may mediate communication 15 between pancreatic and immune cells by transfer of molecular cargo. Nevertheless, studies characterizing the 16 functional landscape of pancreatic beta-cell-derived EVs in T1D, and their implications as biomarkers of T1D 17 susceptibility in childhood, are lacking. In response to RFA-DK-21-016, we hypothesize that pancreatic islet cell- 18 derived EVs are functional reporters of islet cell biology and contain RNA cargo relevant to regulation of immune 19 responses and beta cell health early in T1D. In Aim 1, we utilize well-established human cellular systems of 20 pancreatic injury (human cell-line and donated human islets, with and without cytokine-mediated injury) 21 alongside methods established by our group to provide proteomic and transcriptional characterization of beta- 22 cell-derived EVs, with isolation of pancreatic beta-cell specific EVs from human circulation in children with and 23 without T1D. In Aim 2, we define the functional role for pancreatic beta-cell specific EVs in innate immune 24 function (macrophages, neutrophils) postulated to serve as early mediators of pancreatic injury via assessments 25 of immunometabolic phenotypes and responses to in vivo administration of human EVs to a diabetes-prone 26 model system. In Aim 3, we will use RNA-seq and bioinformatics to identify pancreatic beta cell-specific 27 transcripts associated with incident T1D from children from the long-standing NIDDK TEDDY study (n=140, 1:1 28 T1D case/control) at high immunologic risk for T1D. Upon completion, this application will provide a broad 29 phenotypic, functional and clinical characterization of human beta cell derived EVs toward developing a signature 30 of pancreatic cell-specific EVs relevant to early T1D development, addressing the aims of RFA-DK-21-016.

1型糖尿病（T1D）是一种自身免疫性疾病，在美国有近200万人患有此病